Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cami S Sima

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Applied Health Economics and Health Policy|December 30, 2009
Analytical strategies for characterizing chemotherapy diffusion with patient-level population-based dataCami S Sima, Katherine S Panageas, Glenn Heller, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 22, 2011
Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I casesAkihiko Yoshizawa, Noriko Motoi, Gregory J Riely, et al.
Cancer|June 30, 2017
Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancerEric J Sherman, Lara A Dunn, Alan L Ho, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancerM Catherine Pietanza, Anya M Litvak, Anna M Varghese, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Applied Health Economics and Health Policy|December 30, 2009
Analytical strategies for characterizing chemotherapy diffusion with patient-level population-based dataCami S Sima, Katherine S Panageas, Glenn Heller, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 22, 2011
Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I casesAkihiko Yoshizawa, Noriko Motoi, Gregory J Riely, et al.
Cancer|June 30, 2017
Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancerEric J Sherman, Lara A Dunn, Alan L Ho, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancerM Catherine Pietanza, Anya M Litvak, Anna M Varghese, et al.
Pageof 1